difluprednate 0.5 MG/ML Ophthalmic Suspension [Durezol]
- RxCUI
- 804547
- RxNorm name
- difluprednate 0.5 MG/ML Ophthalmic Suspension [Durezol]
- Display name
- difluprednate 0.5 MG/ML Ophthalmic Suspension [Durezol]
- Full name
- difluprednate 0.5 MG/ML Ophthalmic Suspension [Durezol]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DUREZOL | DIFLUPREDNATE | Sandoz Inc | ea520a27-f569-4b31-8bad-a25ad54b2caa | 2026-08-18 | Warnings, Adverse reactions | 804547 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ea520a27-f569-4b31-8bad-a25ad54b2caa | DUREZOL 0.05 % Ophthalmic Emulsion [PSN] · difluprednate 0.5 MG/ML Ophthalmic Suspension [Durezol] [SBD] · DUREZOL 0.05 % Ophthalmic Emulsion [SY] · Durezol 0.05 % Ophthalmic Suspension [SY] · Durezol 0.5 MG/ML Ophthalmic Suspension [SY] | 5 | 4 | These highlights do not include all the information needed to use DUREZOL safely and effectively. See full prescribing information for DUREZOL. DUREZOL ® (difluprednate ophthalmic emulsion) 0.05%, for topical ophthalmic use Initial U.S. Approval: 2008 | 20251024 |